Send Press Release To Your Friends

PR Title:	GSK announces positive data from Harmony 8 and completion of clinical registration package for albiglutide in type 2 diabetes
PR Summary:	GlaxoSmithKline (GSK) today announced that data have been received from the Phase III Harmony 8 study and from the event driven meta-analysis for assessment of cardiovascular safety conducted across the albiglutide clinical programme.

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message